Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Revenue Per Share for the year ending March 31, 2024: USD 3.92

Yuki Gosei Kogyo Co., Ltd. Revenue Per Share is USD 3.92 for the year ending March 31, 2024, a -11.58% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Yuki Gosei Kogyo Co., Ltd. Revenue Per Share for the year ending March 31, 2023 was USD 4.43, a -4.83% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Revenue Per Share for the year ending March 31, 2022 was USD 4.65, a 1.40% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Revenue Per Share for the year ending March 31, 2021 was USD 4.59, a 0.50% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Revenue Per Share for the year ending March 31, 2020 was USD 4.57, a 7.57% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Health Care
Industries
Pharmaceuticals Chemicals & Advanced Materials Petrochemicals
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email